Description
The
hPRL [125I] IRMA system provides a direct quantitative in
vitro determination of human prolactin hPRL in human serum. hPRL can be
assayed in the range of 0-5000 µIU/ml using 100 µl serum samples. Each
kit contains materials sufficient for 100 assay tubes permitting the
construction of one standard curve and the assay of 42 unknowns in
duplicate.
Introduction
Prolactin
(hPRL) is a protein hormone with a molecular weight of 22000, secreted
by the pituitary gland.
The
hPRL synthesis and release are believed to be controlled by the
prolactin releasing factor although the identity of this is uncertain.
TRH has been shown to stimulate the release of prolactin too. Prolactin
release is under inhibitory control by the prolactin-inhibiting factor
(PIF).
Hyperprolactinemia is a common cause of gonadal dysfunction in women and
men, but there are numerous physiological and pathological conditions
resulted in hyperprolactinemia.
Principle of method
The technology
uses two high affinity monoclonal antibodies in an immunoradiometric
assay (IRMA) system.
The
125I labelled signal-antibody binds to an epitope of the PRL
molecule spatially different from that recognized by the
biotin-capture-antibody. The two antibodies react simultaneously with
the antigen present in standards or samples, which leads to the
formation of a capture antibody - antigen - signal antibody
complex, also referred to as a “sandwich”.
During a
2-hour incubation period with shaking immuno-complex is immobilized to
the reactive surface of streptavidin coated test tubes. Reaction mixture
is then discarded, test tubes washed exhaustively, and the radioactivity
is measured in a gamma counter.
The
concentration of antigen is directly proportional to the radioactivity
measured in test tubes. By constructing a calibration curve plotting
binding values against a series of calibrators containing known amount
of hPRL, the unknown concentration of hPRL in patient samples can
determined
Contents of the kit
|
1 bottle |
TRACER, ready to use.
21 ml, containing about 740 kBq 125I-anti-hPRL and
capture anti-hPRL in buffer with red dye and 0.1% NaN3. |
|
6 vials |
STANDARD, lyophilized.
1 ml per vial, containing 0, 20, 80, 300, 1200, 5000 µIU/ml hPRL
(WHO 3rd IS 84/500 Int. Std.), in human serum with 0.1% NaN3.
See Preparation of reagents |
|
1 vial |
CONTROL SERUM
Lyophilized human serum with 0.1% NaN3.
The concentration of the control serum is specified in
the quality certificate enclosed. See Preparation of
reagents |
|
2 boxes |
COATED TUBE, ready to use.
2 x 50 reactive test tubes, 12x75 mm, packed in plastic boxes. |
|
1 bottle |
WASH BUFFER CONCENTRATE.
20 ml, containing 0.1% NaN3. See Preparation of
reagents |
|
1 pc |
Quality certificate |
|
1 pc |
Pack leaflet |
Materials, and equipment required
Test
tube rack
Precision pipettes with disposable tip (100, 200 and 2000 µl)
Distilled water
Vortex mixer
Gamma counter
Absorbent tissue
Shaker
Plastic foil
Recommended
tools and equipment
Repeating pipettes (e.g. Eppendorf)
Dispenser with 1-L reservoir (instead of the 2 ml pipette)
Specimen collection and storage
Serum
samples can be prepared according to common procedures used routinely in
clinical laboratory practice. Samples can be stored at 2-8 °C if the
assay is carried out within 24 hours, otherwise aliquots should be
prepared and stored deep frozen (-20 °C). Frozen samples should be
thawed and thoroughly mixed before assaying. Repeated freezing and
thawing should be avoided. Do not use lipemic, hemolyzed or turbid
specimens. Samples with a hPRL concentration higher than that of the
most concentrated standard should be diluted and reassayed.
Preparation of reagents, storage
Add the
wash buffer concentrate (20 ml) to 700 ml distilled water to obtain 720
ml wash solution. Upon dilution store at 2-8 °C until expiry date.
Add
1000 µl distilled water to the lyophilized standards and control serum.
Mix gently with shaking or vortexing (foaming should be avoided).
Ensure
that complete dissolution is achieved, and allow the solution to
equilibrate at room temperature for at least 20 minutes. Store at -20 °C
until expiry date.
Store
the rest of reagents between 2-8 °C after opening. At this temperature
each reagent is stable until expiry date. The actual expiry date is
given on the package label and in the quality certificate.
CAUTION! Equilibrate all reagents and serum samples to room temperature.
Mix all reagents and samples thoroughly before use. Avoid excessive
foaming.
Assay procedure
(For a quick
guide, refer to Table 1.)
|
1 |
Equilibrate reagents and samples to room temperature
before use. |
|
2 |
Label coated tubes in duplicate for each standard
(S1-S6), control serum and samples. |
|
3 |
Homogenize all reagents and samples by gentle mixing to
avoid foaming. |
|
4 |
Pipette 100 µl of standards, control and samples into the
properly labelled tubes. Use rack to hold the tubes. Do not
touch or scratch the inner bottom of the tubes with pipette tip. |
|
5 |
Pipette 200 µl of tracer into each tube. |
|
6 |
Seal all tubes with a plastic foil. Fix the test tube
rack firmly onto the shaker plate. Turn on the shaker and adjust
an adequate speed such that liquid is constantly rotating or
shaking in each tube. |
|
7 |
Incubate tubes for 2 hours, shaking at room temperature. |
|
8 |
Add 2.0 ml of diluted wash buffer to each tube. Decant
the supernatant from all tubes by the inversion of the rack. In
the upside down position place the rack on an absorbent paper
for 2 minutes. |
|
9 |
Return the tube-rack to an upright position, and repeat
Step 8 two more times. |
|
10 |
Count each tube for at least 60 seconds in a gamma
counter. |
|
11 |
Calculate the PRL concentrations of the samples as
described in Calculation of results or use special
software. |
Table 1.
Assay Protocol, Pipetting Guide (all volumes in microliters)
|
Tubes |
Total |
Standard |
Sample |
Control |
|
Standard |
|
100 |
|
|
|
Sample |
|
|
100 |
|
|
Control |
|
|
|
100 |
|
Tracer |
200 |
200 |
200 |
200 |
|
Shake for 2 hour at room temperature |
|
Wash
Buffer |
|
2000 |
2000 |
2000 |
|
Decant
the fluid and blot on filter pape |
|
Wash
Buffer |
|
2000 |
2000 |
2000 |
|
Decant
the fluid and blot on filter pape |
|
Wash
Buffer |
|
2000 |
2000 |
2000 |
|
Decant
the fluid and blot on filter pape |
|
Count radioactivity (60 sec/tube) |
|
Calculate the results |
Table 2.
Typical Assay Data
| |
cpm
1 |
cpm
2 |
cpm
mean |
B / T
% |
|
Total |
328034 |
324807 |
326421 |
|
|
S1 |
63 |
74 |
69 |
0.02 |
|
S2 |
926 |
925 |
926 |
0.28 |
|
S3 |
3086 |
3177 |
3132 |
0.96 |
|
S4 |
12100 |
12489 |
12295 |
3.8 |
|
S5 |
45680 |
45462 |
45571 |
14.0 |
|
S6 |
162201 |
162009 |
162105 |
49.7 |
|
C |
10731 |
10724 |
10728 |
3.3 |

Figure 1
A typical standard curve
(Do not use to calculate unknown samples)
Calculation of results
The
calculation is illustrated using representative data. The assay data
collected should be similar to those shown in Table 2.
Calculate the
average CPM for each pair of assay tubes. Calculate the normalized
percent binding for each standard, control and sample respectively by
using the following equation:
| |
S2-6 [C, Mx] (cpm) – S1
(cpm) |
|
|
B / T (%) = |
——————————— |
x 100 |
| |
T (cpm) |
|
Using
semi-logarithmic graph paper plot B/T (%) for each standard versus the
corresponding concentration of PRL.
Determine the
PRL concentration of the unknown samples by interpolation from the
standard curve. Do not extrapolate values beyond the standard curve
range.
Out of fitting
programs applied for computerized data processing logit-log, or spline
fittings can be used. Automated data processing systems are also
available.
Characterization of the assay
Assay
parameters
|
NSB / T |
< 0.04% |
|
Bmax / B0 |
> 1000 |
Sensitivity
A
detection limit of 0.6 µIU/ml has been obtained by assaying 20
duplicates of the zero standard. The sensitivity has been determined as
the concentration corresponding to the sum of the mean cpm and its
double standard deviation.
Hook effect
There
is no high dose “hook effect” up to a hPRL concentration of 10000
µIU/ml.
Specificity
The monoclonal
antibodies used in this IRMA kit are specific for hPRL. No cross
reactivity with hPL, hGH can be detected in normal physiological
concentrations.
Precision
4 patient
samples were assayed in 15 replicates to determine intra-assay
precision. Values obtained are shown below.
|
Sample |
Number
of replicates |
Mean value
µIU/ml |
SD
µIU/ml |
CV
% |
|
1 |
15 |
1412 |
21 |
1.5 |
|
2 |
15 |
825 |
11.7 |
1.4 |
|
3 |
15 |
272 |
4.2 |
1.5 |
|
4 |
15 |
124 |
3.4 |
2.8 |
Reproducibility
To determine
inter-assay precision 6 patients samples were measured in duplicates in
at least 15 independent assays by 2 operators using different kit
batches. Values obtained are shown below.
|
Sample |
Number
of runs |
Mean value
µIU/ml |
SD
µIU/ml |
CV
% |
|
1 |
15 |
1384 |
30 |
2.1 |
|
2 |
15 |
805 |
17 |
2.2 |
|
3 |
15 |
582 |
19 |
3.3 |
|
4 |
15 |
274 |
5 |
1.9 |
|
5 |
15 |
127 |
3 |
2.2 |
|
6 |
15 |
301 |
5 |
1.5 |
Expected Values
Healthy
adults: 80-500 µIU/ml
It is
recommended that each laboratory determine a reference range for its own
patient population.
Procedural notes
1)
Source of error! Reactive test tubes packed in plastic boxes
are not marked individually. Care should be taken of not mixing them
with common test tubes. To minimize this risk, never take more tubes
than needed out of plastic box, and put those left after work back to
the box. It is recommended to label assay tubes by a marker pen.
2)
Source of error! To ensure the efficient rotation, tubes should
be firmed tightly inside the test tube rack. Never use a rack type with
open hole. An uneven or incomplete shaking may result in a poor assay
performance.
3)
Addition of wash buffer. For the addition of wash
buffer the use of a common laboratory dispenser equipped with a 1-L
glass bottle, and a flexible outlet tubing end is recommended. In lack
of this tool a large volume syringe attached to a repeating pipette can
be used.
Additional information
Components
from various lots or from kits of different manufacturers should not be
mixed or interchanged.
Precautions
Radioactivity
This product
contains radioactive material. It is the responsibility of the user to
ensure that local regulations or code of practice related to the
handling of radioactive materials are satisfied.
Biohazard
Human blood
products used in the kit have been obtained from healthy human donors.
They were tested individually by using approved methods (EIA, enzyme
immunoassay), and were found to be negative, for the presence of both
Human Immunodeficiency Virus antibody (Anti-HIV-1) and Hepatitis B
surface Antigen (HBsAg).
Care should
always be taken when handling human specimens to be tested with
diagnostic kits. Even if the subject has been tested, no method can
offer complete assurance that Hepatitis B Virus, Human Immunodeficiency
Virus (HIV-1), or other infectious agents are absent. Human blood
samples should therefore be handled as potentially infectious
materials.
Chemical
hazard
Components contain sodium azide as an antimicrobial agent. Dispose of
waste by flushing with copious amount of water to avoid build-up of
explosive metallic azides in copper and lead plumbing. The total azide
present in each pack is 74 mg.
 |
Use by |
 |
In vitro diagnostic medical device |
 |
Control |
 |
Batch code |
 |
Manufacturer |
 |
Standard |
 |
Caution, consult accompanying documents |
 |
Radioactive material |
 |
Coated tube |
 |
Biological risk |
 |
Temperature limitation
Store between 2-8 °C |
 |
Tracer |
 |
Consult instructions for use |
 |
Catalogue number |
 |
Wash buffer |
|